ID-CapTM Digital Pill System
The ID-Cap is no ordinary pill. It's a digital pill that packs an ingestible wireless sensor called the ID-Tag™. When ingested, the ID-Tag taps into etectRx's unique communication technology to beam a low-power digital signal right from the participant's stomach, tracking when the pill was ingested. The data collected by this digital marvel can be easily accessed through MEMS AS®, a cloud-based medication adherence software, complete with intuitive dashboards and real-time drug adherence insights.
ID-CAP DIGITAL PILL System
FDA-Cleared Adherence-Enhancing Digital Pill
Drug adherence is critical in clinical trials involving oral-dose drugs. Adherence refers to the extent to which patients take their medication as prescribed, and it plays a vital role in determining the safety and efficacy of the drug under investigation. Poor adherence can result in inaccurate study outcomes, increased variability in results, and reduced statistical power, leading to inconclusive or misleading study results. In addition, it can affect the interpretation of the clinical trial's results, making it challenging to determine whether the drug is safe and effective. Therefore, monitoring adherence to oral dose drugs is crucial for clinical trial success, ensuring that the trial outcomes accurately reflect the drug's potential benefits and risks.
Unlike traditional adherence monitoring methods such as pill count, PK sampling, and self-report, the etectRx digital pill system provides a practical way of understanding whether participants engage with the dosing regimen as prescribed without burdening participants or site staff. The ID-Cap System features a capsule with an embedded ingestible wireless sensor called the ID-Tag. When swallowed, the sensor transmits a low-power digital message from inside the stomach, transmitting the date and time of ingestion to a wearable device that detects messages sent from ingested ID-Tags and forwards them using Bluetooth technology to the ID-Cap App on the patient's smartphone.
Under the AARDEX Group integration, the captured data can be transmitted to MEMS AS, medication adherence software that harnesses proprietary algorithms to help sponsors understand patient dosing patterns. Healthcare teams can then use this information to risk-stratify patients, deliver targeted interventions, and boost medication adherence.
FEATURES
Real-Time Drug Adherence Monitoring.
The ID-Cap system integrates with our proprietary Medication Adherence Software, MEMS AS, to provide a comprehensive solution for clinical researchers to monitor adherence to oral dose medications. The user-friendly software includes pre-built dashboards and ranked lists that enable researchers to monitor participant, site, and study adherence patterns. With these readily available insights, researchers can promptly identify potential adherence issues and take the necessary steps to ensure participants adhere to their medication regimens. This all-in-one solution streamlines the monitoring process and empowers researchers to keep participants on track with their medication schedules.
- Fully Scalable
- ISO27001 Certified Datacenter
- HIPAA & GDPR Compliant
- IRT, EDC & DCT Integration
FEATURES
FDA 510(K) Cleared
System.
The ID Cap system is FDA 510(k) cleared, which is a significant achievement. This clearance indicates that the FDA has reviewed and deemed the ID Cap system to be safe and effective for its intended use. The FDA 510(k) clearance process involves evaluating the safety and effectiveness of medical devices that are intended for human use. It involves a rigorous review of the device's design, performance, and clinical data to ensure that it meets the necessary safety and effectiveness standards. This clearance is important because it assures both patients and sponsors that the ID Cap system has undergone rigorous testing and is safe to use.
- Self-Powered by Stomach Fluids
- Looks, Tastes, and Feels Just Like an Ordinary Capsule
FEATURES
Improve Drug Adherence.
Eliminating barriers to medication adherence in clinical trials is paramount for optimizing participant outcomes and maintaining research integrity. We recognize the importance of user-friendly solutions that place no burden on participants, simply requiring them to take their medication as prescribed. In addition, our solutions offer participants access to MEMS® Mobile, a convenient app that allows them to schedule medication reminders, helping them to stay on top of their dosing regimen. Our patient-centric approach to medication adherence strives to empower participants and help them achieve better outcomes.
- User-Friendly App
- IoS & Android Compatible
- Available in 25 Languages
- 20K+ Users in 30 Countries
FEATURES
Unparalleled Accuracy.
Boasting an awe-inspiring 98% user engagement rate, The ID-Cap System is no ordinary solution. It's a high-impact solution that skyrockets patient engagement and dramatically boosts the odds of study success. An 8-month acceptability study recently revealed that patients used the ID-Cap on 1245 out of 1270 use days, and there was no sign of dwindling patient engagement during the course of the study. The ID-Cap's integration with MEMS AS unleashes a whole new world of possibilities for researchers to elevate study outcomes and forge meaningful connections with patients that were once deemed unattainable.
- Patient-Friendly
- Easy-to-Use
OUR CLIENTS
The Go-To Solution for Pharma Companies
Some of the world's leading pharmaceutical companies have embraced our medication adherence solutions. From global giants to niche players, these organizations have recognized the value of our innovative solutions for enhancing medication adherence, reducing costs, and improving patient outcomes. It's an honor to partner with these remarkable brands, and we're proud to contribute to their efforts in advancing healthcare.
Medication Adherence Software →
Learn about our industry-leading adherence software for trials.
Medication Adherence Packaging →
Discover our range of medication adherence packaging.
Medication Adherence Devices→
Discover our range of medication adherence devices.
Got Questions?
Connect with an adherence expert.
Frequently Asked Questions
Drug adherence is a vital yet often overlooked aspect of successful research. That's why we've gone the extra mile to gather and organize the most frequently asked questions about this critical topic. Our goal is to empower researchers and patients alike with the knowledge they need to ensure medication adherence is never a hurdle to progress. So, without further ado, here are the answers you've been looking for!
Digital pills, also known as “smart pills” or “ingestible sensors,” are a type of medication that contains a small sensor or microchip that can communicate with an external device, such as a smartphone, computer, or wearable device. When a patient swallows the it, the sensor is activated by stomach fluids, and it begins to transmit data about the medication to the external device.
Solutions like this typically consists of three main components: the pill, the wearable sensor, and the software platform. The pill contains a tiny sensor that is activated by stomach fluids when it is swallowed. The sensor communicates with the wearable sensor, which is either attached to the patient’s skin or a wearabale, and transmits data about the medication’s dosage, timing, and location. The wearable sensor then sends this data to the software platform, which can be accessed by healthcare providers, researchers, or patients themselves.
The software platform typically includes a dashboard that displays data on drug adherence, dosage, and timing, as well as alerts for missed doses or potential medication interactions. This data can help healthcare providers to monitor patient adherence to medication regimens and make adjustments to treatment plans as needed.
Digital pills have the potential to improve medication adherence and treatment outcomes by providing real-time data on patient medication use and allowing healthcare providers to intervene when necessary.
The ID-Cap System, developed by etectRX, pill system has been cleared by the FDA through the 510(k)clearance process. This innovative system uses a small ingestible sensor that is embedded in a medication capsule and can communicate with an external device to transmit data on medication use, including the time and date of ingestion. The ID-Cap System can help healthcare providers to monitor patient adherence to medication regimens and provide more personalized care.
They are made of a combination of materials that are safe for ingestion and compatible with the body. The outer shell of the digital pill is typically made of an inert material, such as gelatin, that is safe for consumption and can dissolve in stomach acid. Inside the pill, there is a small sensor or microchip that is encased in a protective material, such as a biocompatible polymer, that can withstand the acidic environment of the stomach. The sensor or microchip inside the digital pill is typically made of materials such as silicon, magnesium, or copper that can transmit data wirelessly to an external device.
Drug adherence refers to a patient’s ability to take their medication as prescribed by their healthcare provider. This includes taking the correct dosage at the appropriate time and for the recommended duration. Adherence is essential for ensuring that medications are effective in treating medical conditions, managing symptoms, and preventing disease progression.
Drug adherence can be influenced by a variety of factors, including patient education and understanding of the medication, the complexity of the dosing schedule, side effects, cost, and access to healthcare. Poor adherence can lead to medication errors, treatment failure, and increased healthcare costs. In contrast, good adherence is associated with improved health outcomes, better quality of life, and reduced healthcare costs.
Healthcare providers may use a variety of strategies to improve adherence, such as patient education, simplifying dosing schedules, monitoring medication use, and providing reminders or incentives. By improving drug adherence, healthcare providers can ensure that patients receive the full benefit of their medication, leading to better health outcomes and improved quality of life.
WEBINAR WITH MERCK & BIOGEN
Mitigating the Risk of Poor Adherence in Trials
Watch this live recording with adherence experts from Merck & Biogen to learn about their approach to mitigating the risk of poor adherence in trials.
Collaborating for Safer, More Efficient Trials.
By combining technology and partnerships, we are revolutionizing how medication adherence is monitored in clinical trials. Our unique adherence ecosystem brings together leading medication adherence packaging and devices and DCT, IRT, and EDC vendors, CROs, and CMOs to drive innovation.